MARC details
| 000 -LEADER |
|---|
| fixed length control field |
05019pam a22005051i 4500 |
| 001 - CONTROL NUMBER |
|---|
| control field |
021962587 |
| 005 - DATE AND TIME OF LATEST TRANSACTION |
|---|
| control field |
20250919143241.0 |
| 006 - FIXED-LENGTH DATA ELEMENTS--ADDITIONAL MATERIAL CHARACTERISTICS |
|---|
| fixed length control field |
m || d | |
| 007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION |
|---|
| fixed length control field |
cr ||||||||||| |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
|---|
| fixed length control field |
200113s2020 onca o 000|0|eng|d |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
9781771888608 |
| Qualifying information |
hardback : |
| Terms of availability |
RM738.13 |
| 040 ## - CATALOGING SOURCE |
|---|
| Original cataloging agency |
StDuBDS |
| Language of cataloging |
eng |
| Description conventions |
rda |
| -- |
pn |
| Transcribing agency |
StDuBDS |
| Modifying agency |
Uk |
| -- |
UKM |
| Description conventions |
rda |
| 090 ## - LOCALLY ASSIGNED LC-TYPE CALL NUMBER (OCLC); LOCAL CALL NUMBER (RLIN) |
|---|
| Classification number (OCLC) (R) ; Classification number, CALL (RLIN) (NR) |
QZ267 |
| Local cutter number (OCLC) ; Book number/undivided call number, CALL (RLIN) |
.D794 2021 9 |
| 245 00 - TITLE STATEMENT |
|---|
| Title |
Drug development for cancer and diabetes : |
| Remainder of title |
a path to 2030 / |
| Statement of responsibility, etc. |
edited by K. Saravanan [and five others]. |
| 264 #1 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE |
|---|
| Place of production, publication, distribution, manufacture |
Toronto : |
| Name of producer, publisher, distributor, manufacturer |
Apple Academic Press, |
| Date of production, publication, distribution, manufacture, or copyright notice |
2021. |
| 264 #4 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE |
|---|
| Date of production, publication, distribution, manufacture, or copyright notice |
©2021. |
| 300 ## - PHYSICAL DESCRIPTION |
|---|
| Extent |
xxix, 362 pages : |
| Other physical details |
illustrations ; |
| Dimensions |
24 cm. |
| 336 ## - CONTENT TYPE |
|---|
| Content type term |
text |
| Source |
rdacontent |
| 337 ## - MEDIA TYPE |
|---|
| Media type term |
unmediated2rdacontent |
| 338 ## - CARRIER TYPE |
|---|
| Carrier type term |
volume |
| Source |
rdamedia |
| 504 ## - BIBLIOGRAPHY, ETC. NOTE |
|---|
| Bibliography, etc. note |
Includes bibliographical references and index. |
| 505 0# - FORMATTED CONTENTS NOTE |
|---|
| Formatted contents note |
PART I CANCER AND LEADS FOR CANCER TREATMENT 1. Biomarkers for Screening of Premalignant Lesions and Therapeutic Surveillance Chukwuebuka Egbuna 2. Kinase Targets in Cancer Drug Discovery S. Usha 3. Essential Drug Properties and Stages in Anti-Cancer Drug Development Andrew G. Mtewa, Duncan Sesaazi, Amanjotannu, and Serawit Deyno 4. Plant Constituent as Anti-Cancer Drugs T. Veni, T. Pushpanathan, and G. Vimala 5. Anticancer Properties of Some Effective Phytochemicals Murat Alan and Behnaz Aslanipour 6. Therapeutic Aspects of Some Extracts and Purified Cardiac Glycosides Obtained From Nerium oleander L Behnaz Aslanipour and Murat Alan 7. Challenging Compounds of Some Medicinal Plants Against Cancer N. Shaista Jabeen, L. Jagapriya, B. Senthilkumar, and K. Devi 8. |
| 505 0# - FORMATTED CONTENTS NOTE |
|---|
| Formatted contents note |
Medicinal Plants as Therapeutic Agents in the Treatment of Cancer Jaya Vikaskurhekar 9. Cytotoxic, Apoptosis Inducing Effects and Anti-Cancerous Drug Candidature of Jasmonates Parth Thakor, Ramalingam B. Subramanian, Sampark S. Thakkar, and Vasudev R. Thakkar 10. Apoptosis Activity of 1, 2, -Benzene Dicarboxylic Acid Isolated from Andrographis paniculata on KB, SiHa and IMR Cancer Cell Line P. Krishnamoorthy and D. Kalaiselvan 11. Anticancer Drug Discovery From the Indian Spice Box M. V. N. L. Chaitanya, Santhivardhan Chinni, P. Ramalingam, and Y. Padmanabha Reddy 12. Phytochemical Investigation and Evaluation of Anti-Breast Cancer Activity of Chloroform Extract of Tagetes erecta R. Arul Priya, K. Saravanan, and Chukwaebuka Egbuna 13. Isolation, Identification and In Silico Evaluation of Anticancer Activity of Flavone from Pisum sativum R. Arul Priya, K. |
| 505 0# - FORMATTED CONTENTS NOTE |
|---|
| Formatted contents note |
Saravanan, and P. Karuppannan 14. Functional Lead Phytochemicals from the Rutaceae and Zingeiberaceae Plants for Development of Anticancer Drugs K. Saravanan, B. Umarani, V. Balan, P. Premalatha, and Bir Bahadur 15. In Vitro Anticancer Activity of Biophytum sensitivum on Liver Cancer Lines (HEPG2) M. P. Santhi, K. Saravanan, and P. Karuppannan 16. Saffron and Its Active Ingredients: A Natural Product with Potent Anticancer Property Ashutosh Gupta and Abhay K. Pandey PART I: ANTIDIABETIC DRUG DISCOVERY 17. Effects of Pterocarpus marsupium in the Management of Type 2 Diabetes Mellitus Priscilla Suresh 18. Antidiabetic and Antihyperlipidemic Activities of Cyathea nilgiriensis (Holttum) on STZ Induced Diabetic Rats S. Elavarasi, G. Revathi, K. Saravanan, and Horne Iona Averal 19. |
| 505 0# - FORMATTED CONTENTS NOTE |
|---|
| Formatted contents note |
Antidiabetic Activity of Drug Loaded Chitosan Nanoparticle G. Revathi, S. Elavarasi, and K. Saravanan 20. Antidiabetic Activity of Silver Nanoparticles Biosynthesized Using Ventilago maderaspatana Leaf Extract P. Karuppannan, K. Saravanan, and Horne Iona Averal 21. Hypoglycemic Activity of Biophytum sensitivum Whole Plant Extracts on Alloxan Induced Diabetic Rats C. Renuka, K. Saravanan, and P. Karuppannan 22. Antidiabetic Activity of Ventilago maderaspatana Leaf Extracts on STZ Induced Diabetic Rats P. Karuppannan, K. Saravanan, and P. Premalatha 23. Isolation, Identification, and Molecular Docking of Antidiabetic Compounds of Cyatheia nilgiriensis (Holttum) S. Elavarasi, G. Revathi, and K. Saravanan 24. Antidiabetic Potentials of Major Indian Spices: A Review Pratibha, Hema Lohani, S. Zafar Haider, and Nirpendra K. Chauhan 25. |
| 505 0# - FORMATTED CONTENTS NOTE |
|---|
| Formatted contents note |
Aloe Species: Chemical Composition and Therapeutic Uses in Diabetic Treatment Amit Kumar Singh, Ramesh Kumar, B. Umarani, and Abhay K. Pandey |
| 650 #2 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
Antineoplastic Agents, Phytogenic. |
| 650 #2 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
Neoplasns |
| General subdivision |
drug therapy. |
| 650 #2 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
Antihypertensive Agents. |
| 650 #2 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
Diabetes Mellitus |
| General subdivision |
drug therapy. |
| 650 #2 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
Phytotherapy |
| General subdivision |
methods. |
| 650 #2 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
Drug Discovery. |
| 700 1# - ADDED ENTRY--PERSONAL NAME |
|---|
| Personal name |
Saravanan, K., |
| Relator term |
editor. |
| 700 1# - ADDED ENTRY--PERSONAL NAME |
|---|
| Personal name |
Egbuna, Chukwuebuka, |
| Relator term |
editor. |
| 700 1# - ADDED ENTRY--PERSONAL NAME |
|---|
| Personal name |
Averal, Horne Iona, |
| Relator term |
editor. |
| 700 1# - ADDED ENTRY--PERSONAL NAME |
|---|
| Personal name |
Kannan, S. |
| Relator term |
editor. |
| 907 ## - LOCAL DATA ELEMENT G, LDG (RLIN) |
|---|
| a |
.b16894583 |
| b |
2021-12-06 |
| c |
2021-12-02 |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) |
|---|
| Koha item type |
AM |
| Suppress in OPAC |
No |
| Call number prefix |
QZ267 .D794 2021 9 |
| 949 ## - LOCAL PROCESSING INFORMATION (OCLC) |
|---|
| o |
900157196 |
| 990 ## - EQUIVALENCES OR CROSS-REFERENCES [LOCAL, CANADA] |
|---|
| Link information for 9XX fields |
mfh |
| 991 ## - LOCAL NOTE (NAMA FAKULTI/INSTITUT/PUSAT) |
|---|
| a |
Fakulti Farmasi, KKL |
| 998 ## - LOCAL CONTROL INFORMATION (RLIN) |
|---|
| Library |
PERPUSTAKAAN DR ABDUL LATIFF |
| Operator's initials, OID (RLIN) |
2021-12-06 |
| Cataloger's initials, CIN (RLIN) |
m |
| Material Type (Sierra) |
Printed Books |
| Language |
English |
| Country |
|
| -- |
0 |
| -- |
.b16894583 |
